Competitive Cancer Vaccine technology

Our Vaccines induce the highest levels of immune response (CD4+ , CD8+, antibodies, innate immunity)

Adenoviral vectors

• Superiority to other genetic vectors (DNA and viral)
• Lower prevalence Ad serotypes

Muscle Electro-gene-transfer

• Unlimited potential
• Pioneering work of our group in the field

Design Protein/Peptide vaccines

• Modifications with enhanced immunogenicity